— Know what they know.
Not Investment Advice
Also trades as: HEXO.TO (TSX) · $vol 0M

HEXO NASDAQ

HEXO Corp.
1W: -7.9% 1M: -50.4% 3M: -42.7% 1Y: -75.6% 3Y: -98.3% 5Y: -99.7%
$0.71
Last traded 2023-06-22 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $31.2M mcap · 38M float · 0.934% daily turnover

Cash Flow Trends

Operating Cash Flow
-$117M -170.9% ▼
Capital Expenditures
$35M -7.3% ▼
5Y CAGR: +58.5%
Free Cash Flow
-$151M -100.8% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$16M +113.5% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$23M-$82M-$546M-$115M-$1.1B
Depreciation & Amort.$2M$4M$68M$17M$50M
Stock-Based Comp.$5M$29M$26M$15M$15M
Change in Working Capital-$7M-$72M-$57M$431K-$5M
Other Non-Cash Items-$6M-$4M$420M$40M$936M
Operating Cash Flow-$22M-$128M-$95M-$43M-$117M
— Investing Activities —
Capital Expenditures-$48M-$141M-$110M-$32M-$35M
Acquisitions (Net)$0$36M-$30M-$2M-$386M
Investment Purchases-$203M-$3M$10M$0$0
Investment Sales$0$120M$33M$0$1M
Other Investing-$10M-$19M$14M-$417M$403M
Investing Cash Flow-$260M-$8M-$83M-$452M-$16M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$283M$151M$248M$378M$149M
Financing Cash Flow$283M$151M$248M$378M$149M
Net Change in Cash$889K$15M$71M-$117M$16M
Cash End of Period$39M$114M$184M$67M$83M
Free Cash Flow-$70M-$269M-$204M-$75M-$151M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms